Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0372 USD | +23.42% | +24.00% | -94.69% |
Jun. 11 | Motion for Case Conversion Filed by DMK Pharmaceuticals Corporation | CI |
May. 30 | First Motion for Exclusivity Period Extension Filed by DMK Pharmaceuticals Corporation | CI |
Financials (USD)
Sales 2021 | 2.21M | Sales 2022 | 4.76M | Capitalization | 25.39M |
---|---|---|---|---|---|
Net income 2021 | -45M | Net income 2022 | -26M | EV / Sales 2021 | 31.5 x |
Net cash position 2021 | 20.53M | Net cash position 2022 | 433K | EV / Sales 2022 | 5.25 x |
P/E ratio 2021 |
-1.9
x | P/E ratio 2022 |
-0.96
x | Employees | 12 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 90.68% |
Latest transcript on DMK Pharmaceuticals Corporation
1 day | +23.42% | ||
1 week | +24.00% | ||
Current month | +24.00% | ||
1 month | +24.00% | ||
3 months | -42.77% | ||
6 months | -93.90% | ||
Current year | -94.69% |
Managers | Title | Age | Since |
---|---|---|---|
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 23-05-24 |
Seth Cohen
DFI | Director of Finance/CFO | 42 | 23-10-15 |
Robert H. Uhl
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Howard Birndorf
BRD | Director/Board Member | 74 | 19-08-25 |
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 23-05-24 |
Vickie Reed
BRD | Director/Board Member | 62 | 22-05-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-12 | 0.0372 | +23.42% | 11,648 |
24-06-11 | 0.0301 | +2.73% | 2,197 |
24-06-10 | 0.0293 | -2.33% | 2,783 |
24-06-07 | 0.03 | -8.33% | 3,327 |
24-06-06 | 0.0327 | +9.08% | 6,204 |
Delayed Quote OTC Markets, June 12, 2024 at 01:46 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-94.69% | 375K | |
+48.79% | 781B | |
+41.81% | 639B | |
+19.43% | 330B | |
+7.18% | 293B | |
+17.47% | 248B | |
0.00% | 221B | |
+11.55% | 217B | |
+4.53% | 162B | |
-3.92% | 157B |
- Stock Market
- Equities
- DMKPQ Stock